Effect of the phytotherapeutic agent eviprostat on the bladder in a rat model of bladder overdistension/emptying
Open Access
- 9 November 2012
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 32 (7) , 1031-1037
Abstract
Aims Ischemia–reperfusion injury is an important factor in the development of lower urinary tract symptoms (LUTS) that is partly mediated by the generation of free radicals. We investigate the effect of the phytotherapeutic agent Eviprostat, a treatment for benign prostatic hyperplasia (BPH) that has antioxidant and anti‐inflammatory activity, on urinary bladder blood flow (BBF), and function in a rat model of bladder overdistension and emptying (OE). Methods For 8 days before surgery, OE rats received daily oral Eviprostat (36 mg/kg/day) or vehicle, while sham‐operated animals received vehicle. The bladder was distended by infusion of saline over a period of 2 hr (overdistension) and then emptied. After 24 hr, BBF was measured with a laser speckle blood flow imager. The oxidative‐stress marker malondialdehyde (MDA), proinflammatory cytokines, and myeloperoxidase were determined in the isolated bladder, and histological analysis was performed. Functional contractile responses of bladder strips to electrical field stimulation, carbachol, and KCl were measured. Results Twenty‐four hours after bladder OE, a significant decrease in BBF and significant increases in bladder weight, malondialdehyde, proinflammatory cytokines, and myeloperoxidase were observed. Eviprostat almost completely prevented these changes. Histological analysis of the bladder of OE rats showed hemorrhage, accumulation of leukocytes, desquamation of epithelium, and edema, and Eviprostat suppressed these changes. The reduction in functional contractile forces in the bladder of OE rats was also prevented by Eviprostat. Conclusion Eviprostat‐mediated suppression of increased bladder oxidative stress and inflammation caused by bladder OE may contribute to the improvement of BBF and bladder function by Eviprostat. Neurourol. Urodynam. 32: 1031–1037, 2013.Keywords
This publication has 22 references indexed in Scilit:
- Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitisThe Prostate, 2010
- Interactions between inducible nitric oxide synthase and cyclooxygenase‐2 in response to ischaemia‐reperfusion of rabbit bladderBJU International, 2010
- Acute Vardenafil Administration Improves Bladder Oxygenation in Spontaneously Hypertensive RatsThe Journal of Sexual Medicine, 2010
- Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasiaPhytotherapy Research, 2009
- Effect of the phytotherapeutic agent Eviprostat® on 17β‐estradiol‐induced nonbacterial inflammation in the rat prostateThe Prostate, 2009
- Effects of chronic treatment with vardenafil, a phosphodiesterase 5 inhibitor, on female rat bladder in a partial bladder outlet obstruction modelBJU International, 2009
- Coenzyme Q10 diminishes ischemia–reperfusion induced apoptosis and nerve injury in rabbit urinary bladderNeurourology and Urodynamics, 2008
- Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized ratsBJU International, 2007
- Persistent detrusor overactivity after transurethral resection of the prostate is associated with reduced perfusion of the urinary bladderBJU International, 2007
- Urinary Bladder Blood Flow Changes During the Micturition Cycle in a Conscious Pig ModelJournal of Urology, 1996